ATAI vs BABA · rev $308.0K vs P/E 20, rev $137.30B
ATAI Life Sciences BV (ATAI) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Latest reported ATAI revenue for 2024-12-31 was $308.0K. Net income was -$150.0M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. ATAI currently screens at market cap $555.8M.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
ATAI currently screens at market cap $555.8M. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the ATAI and BABA stock pages for the full models.
Not investment advice.